Picture of Zynerba Pharmaceuticals logo

ZYNE — Zynerba Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall Cap

Brief: Zynerba Pharmaceuticals Reports Q2 Loss Per Share Of $0.25

Aug 9 (Reuters) - Zynerba Pharmaceuticals Inc  ZYNE.O :
    * ZYNERBA PHARMACEUTICALS REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
    * Q2 LOSS PER SHARE $0.25
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.24 -- REFINITIV IBES
DATA
    * ZYNERBA PHARMA - BELIEVES CASH AND CASH EQUIVALENTS AS OF
JUNE
30, 2021 SUFFICIENT TO FUND OPERATIONS AND CAPITAL REQUIREMENTS
WELL INTO H1 OF 2024

Source text for Eikon:  ID:nGNXcl2XR 
Further company coverage:  ZYNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zynerba Pharmaceuticals

See all news